From March 20 to 23, 2024, the European Lung Cancer Congress was held in Prague. David Burger presented a poster titled: ‘Development of an online tool for the management of drug-drug interactions between antithrombotic agents and the ROS1/TRK tyrosine kinase inhibitor repotrectinib’.